Maureen R. Molken

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Development and Validation of an AI Tool for Automated PICO Scoping for the European Joint Clinical Assessment (JCA): A Proof of Concept.

Development and Validation of an AI Tool for Automated PICO Scoping for the European Joint Clinical Assessment (JCA): A Proof of Concept.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 18, 2025

Development and Validation of an Artificial Intelligence Tool for Automated Population, Intervention, Comparator, Outcome Scoping for the European Joint Clinical Assessment: A Proof of Concept.

Development and Validation of an Artificial Intelligence Tool for Automated Population, Intervention, Comparator, Outcome Scoping for the European Joint Clinical Assessment: A Proof of Concept.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 18, 2025

Lifetime Healthcare and Long-Term Care Costs of Heart Failure: Estimates Using Administrative Data from Hospitalized Patients in the Netherlands.

Lifetime Healthcare and Long-Term Care Costs of Heart Failure: Estimates Using Administrative Data from Hospitalized Patients in the Netherlands.

Journal: PharmacoEconomics
Published: August 03, 2025

Functional limitations and mental well-being among frail older adults: the mediating effect of social relationships.

Functional limitations and mental well-being among frail older adults: the mediating effect of social relationships.

Journal: Aging & mental health
Published: April 03, 2025

Characterizing a heterogeneous chronic patient population for redesigning person-centred bundled payment models using risk-mitigating measures.

Characterizing a heterogeneous chronic patient population for redesigning person-centred bundled payment models using risk-mitigating measures.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: March 23, 2024

Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands.

Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands.

Journal: Molecular diagnosis & therapy
Published: March 10, 2024

Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies.

Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies.

Journal: Personalized medicine
Published: September 11, 2023

Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young.

Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young.

Journal: Personalized medicine
Published: September 11, 2023

Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK.

Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK.

Journal: Personalized medicine
Published: September 04, 2023

Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries.

Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries.

Journal: Personalized medicine
Published: September 04, 2023

Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation.

Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation.

Journal: Personalized medicine
Published: August 25, 2023

Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems.

Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems.

Journal: Personalized medicine
Published: August 14, 2023
Showing 1-12 of 21

Last Updated: 09/26/2026